Medtronic releases CoreValve study results; Danaher sells its communications business;

@FiercePharma: Top-read news this weekend: Bayer resolves 200 Trasylol lawsuits. Article | Follow @FiercePharma

@EricPFierce: EU official says hunting wild boar may be spreading African swine fever. Wants it stopped. Story | Follow @EricPFierce

@CarlyHFierce: ICYMI: Novartis employee pleads guilty to bribery in Poland. Story | Follow @CarlyHFierce

> Medtronic ($MDT) said a study of its CoreValve System TAVR found it to be safe and effective alternative for aortic stenosis patients at increased risk for open heart surgery. Release

> On the heels of its $2.1 billion acquisition of dental health company Nobel, Danaher ($DHR) sold its communications business to NetScout Systems for $2.6 billion, as it continues to increase its focus on devices. Story (sub. req.)

> Anaheim, CA-based medical device company ClearFlow announced its PleuraFlow System reduces hospital complications after heart surgery following the release of clinical trial results. Release

> Startup Miroculus is developing a device that can screen for multiple types of cancer through a single blood test. Story

Medical Device News

@FierceMedDev: ICYMI Friday: Deerfield bets up to $125M on nuclear materials used in imaging. Article | Follow @FierceMedDev

@VarunSaxena2: Report warns of cyberattacks against medical devices to extort money. More | Follow @VarunSaxena2

@EmilyWFierce: Device from Bay Area startup detects microRNA in blood to screen for dozens of cancers. Story via Wired | Follow @EmilyWFierce

@MichaelGFierce: With Roche's Herceptin, green tea component doubles drug accumulation in cancer cells. FierceDrugDelivery story | Follow @MichaelGFierce

> Eisai wins FDA nod for a drug to treat chemo-caused nausea. More

> PAD patients gain another treatment option as the FDA approves its first drug-coated balloon. Story

> Harvard scientists develop super-repellent coating technology for commonly used devices. Report

Biotech News

@FierceBiotech: 2014's most successful biotech IPOs. Special report | Follow @FierceBiotech

@JohnCFierce: ICYMI: Gilead wins FDA approval for its hep C combo pill, a blockbuster in the making. Article | Follow @JohnCFierce

@DamianFierce: And finally, wins FDA approval for Harvoni. Release | Follow @DamianFierce

@EmilyMFierce: What It's Like to Carry Your Nobel Prize through Airport Security. Article from Scientific American | Follow @EmilyMFierce

> Smith & Nephew hit by setback as PhIII regenerative med study flops. Story

> Pfizer nabs a fast FDA review for breast cancer pipeline star palbociclib. More

> MGH investigator Tanzi says breakthrough will 'revolutionize' Alzheimer's R&D. Article

CRO News

> Covance and Novartis team up with eyes on Big Data. Article

> Parexel expands in the U.K. after an eClinical buyout. Story

> Clinipace raises $4M after staging 5 buyouts in 5 years. More

> With help from Charles River, AstraZeneca expands its respiratory pipeline. Report

Biotech IT News

> Merck's VC unit invests in data security business. More

> ISB teams with Google for NCI Cancer Genomics Cloud project. Report

> NIH turns on Big Data funding faucet. Story

> Merck and Pfizer join Accenture's Life Sciences Cloud Coalition. News

> VC shop follows Y Combinator into the world of biotech incubators. Article

Animal Health News

> Chronic wasting disease found in Iowa captive deer population. Item

> U.K.'s Pirbright Institute tabbed for $29M in funding to train vet scientists. More

> Pan Genome Systems searching for money to fund new Johne's disease vaccine. Article

> UC Davis researchers solve century-old bluetongue virus mystery. Story

> Three European companies will team to develop VLP vaccines for vet use. Report

Suggested Articles

Flatiron has hired a new chief medical officer as it looks to push on under its new parent in the world of electronic health records and real-world data.

Saga Diagnostics has raised 40 million Swedish kronor, or about $4.1 million, to help develop its ultrasensitive cancer liquid biopsy tests.

Terumo will help Orchestra BioMed develop its sirolimus-eluting balloon in both coronary and peripheral cardiovascular interventions.